These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11844642)

  • 21. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I.
    Ross R; Miell J; Freeman E; Jones J; Matthews D; Preece M; Buchanan C
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):47-54. PubMed ID: 1909610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamine dipeptide-supplemented parenteral nutrition improves the clinical outcomes of critically ill patients: A systematic evaluation of randomised controlled trials.
    Stehle P; Ellger B; Kojic D; Feuersenger A; Schneid C; Stover J; Scheiner D; Westphal M
    Clin Nutr ESPEN; 2017 Feb; 17():75-85. PubMed ID: 28361751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bowel rehabilitative therapy on structural adaptation of remnant small intestine: animal experiment.
    Zhou X; Li YX; Li N; Li JS
    World J Gastroenterol; 2001 Feb; 7(1):66-73. PubMed ID: 11819735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of growth hormone (rhGH) and glutamine supplemented parenteral nutrition on intestinal adaptation in short bowel rats.
    Gu Y; Wu ZH; Xie JX; Jin DY; Zhuo HC
    Clin Nutr; 2001 Apr; 20(2):159-66. PubMed ID: 11327744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutamine supplements in the critically ill.
    D'Souza R; Powell-Tuck J
    J R Soc Med; 2004 Sep; 97(9):425-7. PubMed ID: 15340021
    [No Abstract]   [Full Text] [Related]  

  • 26. Glutamine and antioxidants: status of their use in critical illness.
    van Zanten AR
    Curr Opin Clin Nutr Metab Care; 2015 Mar; 18(2):179-86. PubMed ID: 25590616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.
    Kupfer SR; Underwood LE; Baxter RC; Clemmons DR
    J Clin Invest; 1993 Feb; 91(2):391-6. PubMed ID: 7679407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone.
    Van den Berghe G; Wouters P; Carlsson L; Baxter RC; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3062-70. PubMed ID: 9745404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous treatment with IGF-I and GH additively increases anabolism in parenterally fed rats.
    Lo HC; Hinton PS; Peterson CA; Ney DM
    Am J Physiol; 1995 Aug; 269(2 Pt 1):E368-76. PubMed ID: 7653554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis.
    van Zanten AR; Dhaliwal R; Garrel D; Heyland DK
    Crit Care; 2015 Aug; 19(1):294. PubMed ID: 26283217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlations of growth hormone (GH) and insulin-like growth factor I (IGF-I): effects of exercise and abuse by athletes.
    De Palo EF; Gatti R; Lancerin F; Cappellin E; Spinella P
    Clin Chim Acta; 2001 Mar; 305(1-2):1-17. PubMed ID: 11249917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone together with glutamine-containing total parenteral nutrition maintains muscle glutamine levels and results in a less negative nitrogen balance after surgical trauma.
    Hammarqvist F; Sandgren A; Andersson K; Essén P; McNurlan MA; Garlick PJ; Wernerman J
    Surgery; 2001 May; 129(5):576-86. PubMed ID: 11331450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of parenteral L-glutamine on muscle in the very severely ill.
    Palmer TE; Griffiths RD; Jones C
    Nutrition; 1996 May; 12(5):316-20. PubMed ID: 8875514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organ-specific effects and interactions of acute insulin-like growth factor I (IGF-I) and growth hormone (GH).
    Pascual M; Larralde J; Martínez JA
    Growth Dev Aging; 1995; 59(4):181-91. PubMed ID: 8770610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic consequences of critical illness: acute effects on glutamine and protein metabolism.
    Jackson NC; Carroll PV; Russell-Jones DL; Sönksen PH; Treacher DF; Umpleby AM
    Am J Physiol; 1999 Jan; 276(1):E163-70. PubMed ID: 9886963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined infusion of glutamine and arginine: does it make sense?
    Coëffier M; Déchelotte P
    Curr Opin Clin Nutr Metab Care; 2010 Jan; 13(1):70-4. PubMed ID: 19904200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a role for growth hormone therapy in refractory critical illness?
    Taylor BE; Buchman TG
    Curr Opin Crit Care; 2008 Aug; 14(4):438-44. PubMed ID: 18614909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamine in critically ill patients: is it a fundamental nutritional supplement?
    Martins P
    Rev Bras Ter Intensiva; 2016 Jun; 28(2):100-3. PubMed ID: 27410403
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of glutamine-containing total parenteral nutrition on phagocytic activity and anabolic hormone response in rats undergoing gastrectomy.
    Lee CH; Chiu WC; Chen SC; Wu CH; Yeh SL
    World J Gastroenterol; 2005 Feb; 11(6):817-22. PubMed ID: 15682473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the mechanisms of glutamine action in critically ill patients.
    Oliveira GP; Dias CM; Pelosi P; Rocco PR
    An Acad Bras Cienc; 2010 Jun; 82(2):417-30. PubMed ID: 20563423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.